Combining SGLT2 Inhibitors and GLP-1 RAs May Have Cardiovascular and Renal Benefits in Diabetes [rochester medical weight loss]

Related to This Episode

• 

  Q&A with Heidi Thomas

  Writer & Executive Producer of Combining SGLT2 Inhibitors and GLP-1 RAs May Have Cardiovascular and Renal Benefits in Diabetes [rochester medical weight loss] on the secret of the show.

• 

  Relive the Drama with Gif Recaps

  Miss an episode? Catch up on all things Poplar with our gif recaps.

• 

  Visit the Official Site

  Dive deeper into Combining SGLT2 Inhibitors and GLP-1 RAs May Have Cardiovascular and Renal Benefits in Diabetes [rochester medical weight loss] with cast Q&As, expert blogs, BTS photos, and more!

• 

  Explore the Modern Midwives Blog

  Experienced midwives discuss how Combining SGLT2 Inhibitors and GLP-1 RAs May Have Cardiovascular and Renal Benefits in Diabetes [rochester medical weight loss] intersects with modern day Midwifery.